Regulatory affairs, pharmacovigilance and market access services in Armenia

With a team of professional, experienced locally based consultants, Grove is a highly-respected provider of regulatory, pharmacovigilance and market access services in Armenia.

The Armenian healthcare market has significant potential for the future. Furthermore, registration procedures today are relatively straightforward. The local authorities, however, lack the ability to implement many key regulatory policies. Implementation has been hampered in many cases by a lack of resources and/or training. Registration procedures aside, the regulatory affairs environment remains somewhat chaotic as a result. Access to a local regulatory consulting partner and increasingly to local QPPV services is an essential pre-requisite to executing successful market entry and development.

Grove is a specialist CEE healthcare consulting firm and its expertise spans four key areas:

  • regulatory affairs consulting, including regulatory intelligence
  • pharmacovigilance services
  • market access services, including reimbursement applications
  • market assessment including opportunity evaluation, regulatory risk assessment and information on medical device regulations


For over twenty years Grove has successfully provided regulatory, pharmacovigilance and market access services to a wide range of clients to help them navigate the specifics of the Armenian market. With experienced consultants based full-time in the country, clients gain access to an unrivalled depth of local knowledge and understanding in all areas associated with entering and operating in the market.

Pharmaceutical consulting, regulatory affairs, pharmacovigilance, market access and market assessment services are all key areas of Grove expertise.

Grove services client needs across the following product areas:

  • Pharmaceuticals/medicines/drugs/medicinal products
  • Medical devices
  • Biologics
  • Cosmetics
  • Food and dietary supplements